Gene: Apoc3 (apolipoprotein C-III) Mus musculus
Analyze
Symbol:
Apoc3
Name:
apolipoprotein C-III
Description:
Predicted to have high-density lipoprotein particle receptor binding activity; lipase inhibitor activity; and phospholipid binding activity. Involved in cholesterol metabolic process; triglyceride catabolic process; and triglyceride mobilization. Predicted to localize to the chylomicron; spherical high-density lipoprotein particle; and triglyceride-rich plasma lipoprotein particle. Human ortholog(s) of this gene implicated in chronic kidney disease; cognitive disorder; coronary artery disease; familial hyperlipidemia (multiple); and glucose metabolism disease (multiple). Orthologous to human APOC3 (apolipoprotein C3).
Type:
protein-coding
RefSeq Status:
REVIEWED
Also known as:
apo-CIII; Apoc; apoC-III; apolipoprotein C3
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
APOC3 (apolipoprotein C3) HGNC
Ensembl, HGNC, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):
Apoc3 (apolipoprotein C3) HGNC
NCBI, OMA, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Apoc3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
APOC3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
APOC3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Apoc3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
APOC3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
APOC3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Apoc3 (apolipoprotein C3) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Apoc3 (apolipoprotein C3)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB)
Homo sapiens (human):
APOC3 (apolipoprotein C3)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm38 Ensembl 9 46,232,933 - 46,235,636 (-) Ensembl GRCm38 9 46,233,050 - 46,235,636 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 MGSCv37 9 46,041,134 - 46,043,380 (-) NCBI GRCm37 mm9 NCBIm37 MGSCv36 9 45,984,046 - 45,986,292 (-) NCBI mm8 Celera 9 43,522,001 - 43,524,576 (-) NCBI Celera Cytogenetic Map 9 A5.2 NCBI cM Map 9 25.36 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
Imported Annotations - ClinVar
apolipoprotein C-III deficiency ISO RGD:737569 8554872 ClinVar Annotator: match by term: Hyperalphalipoproteinemia 2 ClinVar PMID:24941081 , PMID:24941082 apolipoprotein C-III deficiency ISO RGD:737569 8554872 ClinVar Annotator: match by term: Hyperalphalipoproteinemia 2 ClinVar apolipoprotein C-III deficiency ISO RGD:737569 8554872 ClinVar Annotator: match by term: Hyperalphalipoproteinemia 2 ClinVar PMID:24941081 more ... apolipoprotein C-III deficiency ISO RGD:737569 8554872 ClinVar Annotator: match by term: Hyperalphalipoproteinemia 2 ClinVar PMID:19074352 more ... apolipoprotein C-III deficiency ISO RGD:737569 8554872 ClinVar Annotator: match by OMIM:614028 ClinVar PMID:2022742 apolipoprotein C-III deficiency ISO RGD:737569 8554872 ClinVar Annotator: match by term: Hyperalphalipoproteinemia 2 ClinVar PMID:24941081 Coronary Disease ISO RGD:737569 8554872 ClinVar Annotator: match by term: Coronary heart disease ClinVar PMID:24941081 Coronary Disease ISO RGD:737569 8554872 ClinVar Annotator: match by term: Coronary heart disease ClinVar PMID:24941081 more ... Coronary Disease ISO RGD:737569 8554872 ClinVar Annotator: match by term: Coronary heart disease ClinVar PMID:19074352 more ... Coronary Disease ISO RGD:737569 8554872 ClinVar Annotator: match by term: Coronary heart disease ClinVar PMID:24941081 , PMID:24941082
Imported Annotations - CTD
cardiovascular system disease ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:16544732 celiac disease ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:30097691 coronary artery disease ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:24097064 Drug Eruptions ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:21055120 Hyperlipoproteinemia Type II ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:16030523 Hyperlipoproteinemias ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:2022742 Lung Neoplasms ISO RGD:737569 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:19180532 Imported Annotations - Genetic Association Database
coronary artery disease ISO RGD:737569 1331525 GAD myocardial infarction ISO RGD:737569 1331525 GAD obesity ISO RGD:737569 1331525 GAD Imported Annotations - OMIM
apolipoprotein C-III deficiency ISO RGD:737569 7240710 OMIM
(+)-schisandrin B multiple interactions ISO RGD:2136 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of APOC3 mRNA] CTD PMID:31150632 (-)-ephedrine multiple interactions ISO RGD:737569 6480464 [Ephedrine co-treated with Caffeine co-treated with pioglitazone] results in decreased expression of APOC3 protein CTD PMID:16324916 1-methylphenanthrene multiple interactions ISO RGD:737569 6480464 [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of APOC3 mRNA CTD PMID:17690111 1-nitropropane increases expression ISO RGD:2136 6480464 1-nitropropane results in increased expression of APOC3 mRNA CTD PMID:17070881 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737569 6480464 Tetrachlorodibenzodioxin results in decreased expression of APOC3 mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of APOC3 mRNA CTD PMID:28213091 2,4-diaminotoluene decreases expression ISO RGD:2136 6480464 2, 4-diaminotoluene results in decreased expression of APOC3 mRNA CTD PMID:17070881 2,6-diaminotoluene decreases expression ISO RGD:2136 6480464 2, 6-diaminotoluene results in decreased expression of APOC3 mRNA CTD PMID:17070881 2-acetamidofluorene decreases expression ISO RGD:2136 6480464 2-Acetylaminofluorene results in decreased expression of APOC3 mRNA CTD PMID:17070881 2-nitro-p-phenylenediamine decreases expression ISO RGD:2136 6480464 2-nitro-4-phenylenediamine results in decreased expression of APOC3 mRNA CTD PMID:17070881 2-nitropropane decreases expression ISO RGD:2136 6480464 2-nitropropane results in decreased expression of APOC3 mRNA CTD PMID:17070881 3,7-dihydropurine-6-thione decreases expression ISO RGD:2136 6480464 Mercaptopurine results in decreased expression of APOC3 mRNA CTD PMID:23358152 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [Dietary Fats co-treated with bis(4-hydroxyphenyl)sulfone] affects the expression of APOC3 mRNA CTD PMID:27241191 4-acetylaminofluorene decreases expression ISO RGD:2136 6480464 4-acetylaminofluorene results in decreased expression of APOC3 mRNA CTD PMID:17070881 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of APOC3 mRNA CTD PMID:28973697 4-nitro-1,2-phenylenediamine decreases expression ISO RGD:2136 6480464 1, 2-diamino-4-nitrobenzene results in decreased expression of APOC3 mRNA CTD PMID:17070881 aflatoxin B1 affects expression ISO RGD:737569 6480464 Aflatoxin B1 affects the expression of APOC3 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:737569 6480464 Aflatoxin B1 results in decreased expression of APOC3 mRNA CTD PMID:27153756 azathioprine decreases expression ISO RGD:737569 6480464 Azathioprine results in decreased expression of APOC3 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of APOC3 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:737569 6480464 Benzo(a)pyrene results in decreased expression of APOC3 mRNA CTD PMID:21632981 more ... benzo[a]pyrene multiple interactions ISO RGD:737569 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:737569 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene multiple interactions ISO RGD:737569 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of APOC3 mRNA CTD PMID:17690111 bexarotene decreases expression ISO RGD:2136 6480464 bexarotene results in decreased expression of APOC3 mRNA CTD PMID:16648578 bezafibrate decreases expression ISO RGD:737569 6480464 Bezafibrate results in decreased expression of APOC3 protein CTD PMID:11164425 , PMID:9041378 bezafibrate decreases expression ISO RGD:2136 6480464 Bezafibrate results in decreased expression of APOC3 mRNA, Bezafibrate results in decreased expression of APOC3 protein CTD PMID:8847480 bezafibrate multiple interactions EXP 6480464 PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOC3 mRNA], PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOC3 mRNA] CTD PMID:12782154 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of APOC3 mRNA CTD PMID:12782154 , PMID:19124612 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 bisphenol A decreases expression ISO RGD:2136 6480464 bisphenol A results in decreased expression of APOC3 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:2136 6480464 bisphenol A affects the expression of APOC3 mRNA CTD PMID:30903817 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 bisphenol A affects expression ISO RGD:737569 6480464 bisphenol A affects the expression of APOC3 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of APOC3 mRNA CTD PMID:28483554 bromobenzene decreases expression ISO RGD:2136 6480464 bromobenzene results in decreased expression of APOC3 mRNA CTD PMID:12628495 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of APOC3 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:737569 6480464 butyraldehyde results in decreased expression of APOC3 mRNA CTD PMID:26079696 caffeine multiple interactions ISO RGD:737569 6480464 [Ephedrine co-treated with Caffeine co-treated with pioglitazone] results in decreased expression of APOC3 protein CTD PMID:16324916 calcium dichloride increases expression ISO RGD:737569 6480464 Calcium Chloride results in increased expression of APOC3 protein CTD PMID:25824407 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of APOC3 mRNA CTD PMID:25620056 chenodeoxycholic acid multiple interactions EXP 6480464 Chenodeoxycholic Acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of APOC3 mRNA] CTD PMID:27773935 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in increased expression of APOC3 mRNA more ... CTD PMID:27773935 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of APOC3 mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:737569 6480464 Cisplatin results in decreased expression of APOC3 mRNA CTD PMID:11099651 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of APOC3 protein CTD PMID:31493026 clofibrate decreases expression ISO RGD:2136 6480464 Clofibrate results in decreased expression of APOC3 mRNA, Clofibrate results in decreased expression of APOC3 protein CTD PMID:12851107 , PMID:8847480 cobalt dichloride decreases expression ISO RGD:2136 6480464 cobaltous chloride results in decreased expression of APOC3 mRNA CTD PMID:24386269 copper atom affects binding ISO RGD:737569 6480464 APOC3 protein binds to Copper CTD PMID:23896426 copper(0) affects binding ISO RGD:737569 6480464 APOC3 protein binds to Copper CTD PMID:23896426 copper(II) sulfate decreases expression ISO RGD:737569 6480464 Copper Sulfate results in decreased expression of APOC3 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:737569 6480464 Cyclosporine results in decreased expression of APOC3 mRNA CTD PMID:20106945 , PMID:25562108 daunorubicin increases expression ISO RGD:2136 6480464 Daunorubicin results in increased expression of APOC3 protein CTD PMID:7637207 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of APOC3 mRNA CTD PMID:11162775 dexamethasone multiple interactions ISO RGD:2136 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of APOC3 mRNA] CTD PMID:20032058 dexamethasone increases expression ISO RGD:2136 6480464 Dexamethasone results in increased expression of APOC3 mRNA CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [Dexamethasone results in increased expression of APOC3 mRNA] CTD PMID:11162775 diamminedichloroplatinum decreases expression ISO RGD:737569 6480464 transplatin results in decreased expression of APOC3 mRNA CTD PMID:11099651 dibenz[a,h]anthracene multiple interactions ISO RGD:737569 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene multiple interactions ISO RGD:737569 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] affects the expression of APOC3 mRNA CTD PMID:17690111 ethanol increases expression ISO RGD:2136 6480464 Ethanol results in increased expression of APOC3 mRNA CTD PMID:17920746 fenofibrate affects expression ISO RGD:2136 6480464 Fenofibrate affects the expression of APOC3 mRNA CTD PMID:20801182 fenofibrate decreases expression ISO RGD:737569 6480464 Fenofibrate results in decreased expression of APOC3 mRNA, Fenofibrate results in decreased expression of APOC3 protein CTD PMID:24752549 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of APOC3 mRNA CTD PMID:24752549 fenofibrate decreases expression ISO RGD:2136 6480464 Fenofibrate results in decreased expression of APOC3 mRNA, Fenofibrate results in decreased expression of APOC3 protein CTD PMID:10799317 , PMID:8847480 fluoranthene multiple interactions ISO RGD:737569 6480464 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of APOC3 mRNA CTD PMID:17690111 furan decreases expression ISO RGD:2136 6480464 furan results in decreased expression of APOC3 mRNA CTD PMID:15120968 more ... gemfibrozil decreases expression ISO RGD:2136 6480464 Gemfibrozil results in decreased expression of APOC3 mRNA, Gemfibrozil results in decreased expression of APOC3 protein CTD PMID:8847480 ginsenoside Rf decreases expression EXP 6480464 ginsenoside Rf results in decreased expression of APOC3 protein CTD PMID:16297877 ginsenoside Rf multiple interactions EXP 6480464 ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOC3 mRNA] more ... CTD PMID:16297877 ginsenoside Rf increases expression EXP 6480464 ginsenoside Rf results in increased expression of APOC3 mRNA CTD PMID:16297877 high-density lipoprotein cholesterol affects abundance ISO RGD:737569 6480464 APOC3 gene polymorphism affects the abundance of Cholesterol, HDL CTD PMID:16030523 hydrazine decreases expression ISO RGD:2136 6480464 hydrazine results in decreased expression of APOC3 mRNA CTD PMID:15370871 hydrogen peroxide affects expression ISO RGD:737569 6480464 Hydrogen Peroxide affects the expression of APOC3 mRNA CTD PMID:20044591 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in increased expression of APOC3 mRNA more ... CTD PMID:27773935 linalool decreases expression EXP 6480464 linalool results in decreased expression of APOC3 mRNA CTD PMID:24752549 linalool decreases expression ISO RGD:737569 6480464 linalool results in decreased expression of APOC3 mRNA, linalool results in decreased expression of APOC3 protein CTD PMID:24752549 menadione affects expression ISO RGD:737569 6480464 Vitamin K 3 affects the expression of APOC3 mRNA CTD PMID:20044591 mercaptopurine decreases expression ISO RGD:2136 6480464 Mercaptopurine results in decreased expression of APOC3 mRNA CTD PMID:23358152 methapyrilene decreases expression ISO RGD:2136 6480464 Methapyrilene results in decreased expression of APOC3 mRNA CTD PMID:15120968 methylmercury chloride decreases expression ISO RGD:737569 6480464 methylmercuric chloride results in decreased expression of APOC3 mRNA CTD PMID:23179753 microcystin-LR affects expression EXP 6480464 cyanoginosin LR affects the expression of APOC3 protein CTD PMID:26984711 N-nitrosodiethylamine decreases expression ISO RGD:737569 6480464 Diethylnitrosamine results in decreased expression of APOC3 mRNA CTD PMID:21527772 nickel atom affects binding ISO RGD:737569 6480464 APOC3 protein binds to Nickel CTD PMID:23896426 obeticholic acid decreases expression ISO RGD:737569 6480464 obeticholic acid results in decreased expression of APOC3 mRNA CTD PMID:27939613 olanzapine affects response to substance ISO RGD:2136 6480464 APOC3 gene polymorphism affects the susceptibility to olanzapine CTD PMID:17726453 oleic acid multiple interactions ISO RGD:737569 6480464 [Oleic Acid co-treated with muraglitazar] results in increased expression of APOC3 mRNA more ... CTD PMID:24534255 oxybenzone increases expression ISO RGD:2136 6480464 oxybenzone results in increased expression of APOC3 mRNA CTD PMID:30316929 p-toluidine decreases expression ISO RGD:2136 6480464 4-toluidine results in decreased expression of APOC3 mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:737569 6480464 Acetaminophen results in decreased expression of APOC3 mRNA CTD PMID:26690555 , PMID:29067470 perfluorononanoic acid multiple interactions EXP 6480464 PPARA gene mutant form inhibits the reaction [perfluorononanoic acid results in decreased expression of APOC3 mRNA] CTD PMID:28049043 perfluorononanoic acid decreases expression EXP 6480464 perfluorononanoic acid results in decreased expression of APOC3 mRNA CTD PMID:28049043 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of APOC3 mRNA CTD PMID:17681415 , PMID:30657992 perfluorooctanoic acid decreases expression ISO RGD:2136 6480464 perfluorooctanoic acid results in decreased expression of APOC3 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:2136 6480464 Phenobarbital results in decreased expression of APOC3 mRNA CTD PMID:19162173 pioglitazone multiple interactions ISO RGD:737569 6480464 [Ephedrine co-treated with Caffeine co-treated with pioglitazone] results in decreased expression of APOC3 protein CTD PMID:16324916 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of APOC3 mRNA more ... CTD PMID:11162775 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of APOC3 mRNA, pirinixic acid results in decreased expression of APOC3 protein CTD PMID:11162775 more ... pirinixic acid decreases expression ISO RGD:2136 6480464 pirinixic acid results in decreased expression of APOC3 mRNA CTD PMID:19162173 , PMID:22484513 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of APOC3 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:2136 6480464 Pregnenolone Carbonitrile results in decreased expression of APOC3 mRNA CTD PMID:19162173 purine-6-thiol decreases expression ISO RGD:2136 6480464 Mercaptopurine results in decreased expression of APOC3 mRNA CTD PMID:23358152 quercetin affects expression ISO RGD:737569 6480464 Quercetin affects the expression of APOC3 mRNA CTD PMID:21632981 simvastatin decreases expression ISO RGD:2136 6480464 Simvastatin results in decreased expression of APOC3 mRNA CTD PMID:25055962 sodium arsenite decreases expression ISO RGD:737569 6480464 sodium arsenite results in decreased expression of APOC3 mRNA CTD PMID:29301061 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of APOC3 protein CTD PMID:28918527 Tesaglitazar multiple interactions ISO RGD:737569 6480464 [Oleic Acid co-treated with tesaglitazar] results in increased expression of APOC3 mRNA CTD PMID:24534255 testosterone multiple interactions ISO RGD:2136 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of APOC3 mRNA] CTD PMID:20032058 tetrachloroethene decreases expression EXP 6480464 Tetrachloroethylene results in decreased expression of APOC3 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:2136 6480464 Carbon Tetrachloride results in decreased expression of APOC3 mRNA CTD PMID:16239168 , PMID:31150632 tetrachloromethane multiple interactions ISO RGD:2136 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of APOC3 mRNA] CTD PMID:31150632 tetrachloromethane affects expression ISO RGD:2136 6480464 Carbon Tetrachloride affects the expression of APOC3 mRNA CTD PMID:15963342 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of APOC3 mRNA CTD PMID:16917069 tetramethylpyrazine decreases expression ISO RGD:737569 6480464 tetramethylpyrazine results in decreased expression of APOC3 mRNA CTD PMID:15520497 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of APOC3 mRNA CTD PMID:23409001 , PMID:23557971 transplatin decreases expression ISO RGD:737569 6480464 transplatin results in decreased expression of APOC3 mRNA CTD PMID:11099651 urethane decreases expression ISO RGD:737569 6480464 Urethane results in decreased expression of APOC3 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:737569 6480464 Valproic Acid results in decreased expression of APOC3 mRNA CTD PMID:23179753 , PMID:29154799 valproic acid affects expression ISO RGD:737569 6480464 Valproic Acid affects the expression of APOC3 mRNA CTD PMID:25979313
Gene-Chemical Interaction Annotations
